FirstEnergy Corp. (FE)

Revance Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	13,459	12,938	12,269	11,588	10,428	10,118
Other Revenue	405	348	416	680	515	489
Revenue	13,864	13,286	12,685	12,268	10,943	10,607
Revenue Growth (YoY)	6.52%	4.74%	3.40%	12.11%	3.17%	-2.19%
Fuel & Purchased Power	4,588	4,376	4,646	4,593	3,445	3,070
Selling, General & Admin	91	91	79	73	71	60
Depreciation & Amortization	1,629	1,581	1,461	1,375	1,302	1,274
Other Operating Expenses	4,898	4,904	4,401	3,939	3,248	4,518
Total Operating Expenses	11,206	10,952	10,587	9,980	8,066	8,922
Operating Income	2,659	2,334	2,098	2,288	2,877	1,685
Interest Expense	-1,048	-1,071	-1,071	-1,011	-1,112	-1,037
Net Interest Expense	-1,048	-1,071	-1,071	-1,011	-1,112	-1,037
Income (Loss) on Equity Investments	15	58	175	168	31	2
Allowance for Equity Funds for Construction	61	60	44	56	48	49
Other Non-Operating Income (Expenses)	203	208	254	109	-162	430
EBT Excluding Unusual Items	1,890	1,589	1,500	1,610	1,682	1,129
Gain (Loss) on Sale of Assets	-	-	-	-	109	-
Other Unusual Items	-24	-85	-36	-171	-232	-
Pretax Income	1,885	1,504	1,464	1,439	1,559	1,129
Income Tax Expense	391	377	267	1,000	320	126
Earnings From Continuing Ops.	1,494	1,127	1,197	439	1,239	1,003
Earnings From Discontinued Ops.	-	-	-21	-	44	76
Net Income to Company	1,494	1,127	1,176	439	1,283	1,079
Minority Interest in Earnings	-186	-149	-74	-33	-	-
Net Income	1,308	978	1,102	406	1,283	1,079
Net Income to Common	1,308	978	1,102	406	1,283	1,079
Net Income Growth	49.83%	-11.25%	171.43%	-68.36%	18.91%	18.31%
Shares Outstanding (Basic)	576	575	573	571	545	542
Shares Outstanding (Diluted)	578	577	574	572	546	543
Shares Change (YoY)	0.52%	0.52%	0.35%	4.76%	0.55%	0.18%
EPS (Basic)	2.27	1.70	1.92	0.71	2.35	1.99
EPS (Diluted)	2.27	1.70	1.92	0.71	2.35	1.99
EPS Growth	49.18%	-11.61%	170.88%	-69.80%	18.12%	18.12%
Free Cash Flow	-983	-1,139	-1,969	-165	324	-1,234
Free Cash Flow Per Share	-1.70	-1.97	-3.43	-0.29	0.59	-2.27
Dividend Per Share	1.720	1.685	1.580	1.560	1.560	1.560
Dividend Growth	5.20%	6.65%	1.28%	-	-	1.96%
Profit Margin	9.44%	7.36%	8.69%	3.31%	11.72%	10.17%
Free Cash Flow Margin	-7.09%	-8.57%	-15.52%	-1.34%	2.96%	-11.63%
EBITDA	4,534	4,153	3,639	3,970	4,272	2,937
EBITDA Margin	32.70%	31.26%	28.69%	32.36%	39.04%	27.69%
D&A For EBITDA	1,875	1,819	1,541	1,682	1,395	1,252
EBIT	2,659	2,334	2,098	2,288	2,877	1,685
EBIT Margin	19.18%	17.57%	16.54%	18.65%	26.29%	15.89%
Effective Tax Rate	20.74%	25.07%	18.24%	69.49%	20.53%	11.16%
Revenue as Reported	14,050	13,472	12,870	12,459	11,132	10,790

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.

SEC Filings: 10-K · 10-Q